US Stock MarketDetailed Quotes

ACRV Acrivon Therapeutics

Watchlist

9.460
+0.100+1.07%

Close Aug 26 16:00 ET

293.00MMarket Cap-3477P/E (TTM)

Acrivon Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Acrivon Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	-- / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q3-- / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Acrivon Therapeutics Earnings Reports

Acrivon Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 13 07:42 ET

Acrivon Therapeutics | 10-Q: Q1 2024 Earnings Report

May 14 07:34 ET

Acrivon Therapeutics | 10-K: FY2023 Annual Report

Mar 28 07:39 ET

Acrivon Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 9, 2023 08:02 ET

Analyst Rating

Updated: Aug 16, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall